Latest filings (excl ownership)
NT 10-K
Notice of late annual filing
2 Apr 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
22 Mar 24
424B3
Prospectus supplement
7 Mar 24
424B3
Prospectus supplement
29 Feb 24
424B3
Prospectus supplement
15 Feb 24
EFFECT
Notice of effectiveness
9 Feb 24
CORRESP
Correspondence with SEC
6 Feb 24
UPLOAD
Letter from SEC
5 Feb 24
S-3
Shelf registration
29 Jan 24
8-K
Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio
22 Jan 24
8-K/A
Entry into a Material Definitive Agreement
29 Dec 23
8-K
Cosmos Health Set for Substantial Growth From Acquisitions Completed in 2023
29 Dec 23
8-K
Departure of Directors or Certain Officers
28 Nov 23
8-K
Cosmos Health Reports Q3 2023 Results; Revenue Increased 7% YoY, Total Assets Reached Record $71.5M with Stockholders' Equity of $44.2M or $3.4/Share
22 Nov 23
10-Q
2023 Q3
Quarterly report
20 Nov 23
NT 10-Q
Notice of late quarterly filing
14 Nov 23
8-K
COSMOS HEALTH CEO Issues Letter to Shareholders
10 Oct 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
3 Oct 23
8-K
Departure of Directors or Certain Officers
22 Sep 23
8-K
Other Events
14 Sep 23
DEF 14A
Definitive proxy
5 Sep 23
EFFECT
Notice of effectiveness
1 Sep 23
424B3
Prospectus supplement
31 Aug 23
CORRESP
Correspondence with SEC
29 Aug 23
UPLOAD
Letter from SEC
25 Aug 23
PRE 14A
Preliminary proxy
23 Aug 23
S-3
Shelf registration
18 Aug 23
8-K
Results of Operations and Financial Condition
15 Aug 23
10-Q
2023 Q2
Quarterly report
15 Aug 23
NT 10-Q
Notice of late quarterly filing
14 Aug 23
8-K
Changes in Registrant's Certifying Accountant
7 Aug 23
D
$5.25 mm in equity / options, sold $5.25 mm, 3 investors
27 Jul 23
8-K
Cosmos Health Inc. Announces Pricing of $5.25 Million Registered Direct Offering and Concurrent Private Placement
25 Jul 23
424B5
Prospectus supplement for primary offering
21 Jul 23
424B5
Prospectus supplement for primary offering
21 Jul 23
8-K
Anticipates to Record a Substantial Gain on Bargain Purchase
6 Jul 23
8-K
Other Events
31 May 23
10-Q
2023 Q1
Quarterly report
16 May 23
NT 10-Q
Notice of late quarterly filing
15 May 23
8-K
Entry into a Material Definitive Agreement
11 May 23
Latest ownership filings
4
Grigorios Siokas
21 Feb 24
SC 13G
ARMISTICE CAPITAL, LLC
14 Feb 24
4
Anastasios Aslidis
22 Dec 23
4
Georgios Terzis
26 Oct 23
4
Grigorios Siokas
12 Oct 23
3
Suhel Bhutawala
21 Sep 23
4
Anastasios Aslidis
15 Aug 23
4
Manfred Ziegler
4 Aug 23
3
Manfred Ziegler
4 Aug 23
4
John James Hoidas
1 Aug 23
4
Nikolaos Bardakis
1 Aug 23
4
Georgios Terzis
28 Jul 23
4
Pavlos Ignatiades
28 Jul 23
SC 13D/A
Siokas Grigorios
25 Jul 23
4
Grigorios Siokas
24 Jul 23
4
Grigorios Siokas
7 Jun 23
4
Grigorios Siokas
28 Apr 23
4
Grigorios Siokas
21 Apr 23
4
Grigorios Siokas
10 Apr 23
3
Nikolaos Bardakis
16 Feb 23
4/A
Grigorios Siokas
27 Jan 23
SC 13D/A
Siokas Grigorios
23 Dec 22
4
Grigorios Siokas
21 Dec 22
4
Grigorios Siokas
2 Dec 22
4
Grigorios Siokas
1 Dec 22
4/A
Grigorios Siokas
29 Nov 22
4
Grigorios Siokas
28 Nov 22
SC 13D
Kolefas Athanasios
4 Nov 22
SC 13D/A
Siokas Grigorios
25 Oct 22
4
Grigorios Siokas
24 Oct 22
5
Georgios Terzis
2 Sep 22
SC 13D
Siokas Grigorios
4 Aug 22
4/A
Grigorios Siokas
4 Aug 22
4
Grigorios Siokas
22 Jul 22
3
Anastasios Aslidis
9 May 22
SC 13G/A
Siokas Grigorios
11 Feb 22
SC 13G/A
Hudson Bay Capital Management LP
4 Feb 22
4
Grigorios Siokas
14 Dec 21
4
Grigorios Siokas
22 Oct 21
4
PETER GOLDSTEIN
28 Jul 21